Globus Medical (GMED) Tops Q1 EPS by 5c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Globus Medical Reports First Quarter 2018 Results
May 2, 2018 4:15 PM EDTAUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018.
Worldwide sales were $174.4 million, an increase of 11.9% as reported, or 10.8% in constant currencyFirst quarter net income was $39.5 million, or 22.7% of salesDiluted earnings per share (EPS) were $0.39Non-GAAP diluted EPS were $0.41Non-GAAP adjusted EBITDA was 35.4% of salesWe had a strong first quarter with worldwide sales up 11.9% over the first quarter of 2017 at $174... More
